From melanocyte to metastatic malignant melanoma

Dermatology Research and Practice

Volumn 2010, Issue 1, 2010, Pages

  Bandarchi, Bizhan ^a   Ma, Linglei ^b   Navab, Roya ^a   Seth, Arun ^c   Rasty, Golnar ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867319509     PISSN: None     EISSN: 16876113     Source Type: Journal    
DOI: 10.1155/2010/583748     Document Type: Review

References (113)

1. Williams I. R., Kupper T. S., Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sciences 1996 58 18 1485 1507 2-s2.0-0029933394 10.1016/0024-3205(96)00042-2 (Pubitemid 26130521)
2. Streilein J. W., Toews G. B., Bergstresser P. R., Corneal allografts fail to express Ia antigens. Nature 1979 282 5736 326 327 2-s2.0-0018569160 (Pubitemid 10198537)
3. Fitzpatrick T. B., The biology of pigmentation. Birth Defects Original Article Series 1971 7 8 5 12 2-s2.0-0015068852
4. Nordlund J. J., Boissy R. E., Freinkel R. K., Woodley D. T., The biology of Melanocytes. The Biology of the Skin 2001 New York, NY, USA Parthenon Publishing 113 131
5. Haaka A., Scott G. A., Freinkel R. K., Woodley D. T., Structure and function of the skin: overview of the epidermis and dermis. The Biology of the Skin 2001 New York, NY, USA Parthenon Publishing 19 46
6. Fleischman R. A., Saltman D. L., Stastny V., Zneimer S., Deletion of the c-kit protooncogene in the human developmental defect piebald trait. Proceedings of the National Academy of Sciences of the United States of America 1991 88 23 10885 10889 2-s2.0-0025836661 (Pubitemid 21915943)
7. Grichnik J. M., Burch J. A., Burchette J., Shea C. R., The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. Journal of Investigative Dermatology 1998 111 2 233 238 2-s2.0-0031927710 10.1046/j.1523-1747.1998.00272.x (Pubitemid 28354709)
8. Orlow S. J., Melanosomes are specialized members of the lysosomal lineage of organelles. Journal of Investigative Dermatology 1995 105 1 3 7 2-s2.0-0029081168
9. Hearing V. J., Jiménez M., Analysis of mammalian pigmentation at the molecular level. Pigment Cell Research 1989 2 2 75 85 2-s2.0-0024635537
10. Naeyaert J. M., Eller M., Gordon P. R., Park H.-Y., Gilchrest B. A., Pigment content of cultured human melanocytes does not correlate with tyrosinase message level. British Journal of Dermatology 1991 125 4 297 303 2-s2.0-0026015177 10.1111/j.1365-2133.1991.tb14161.x
11. Bolognia J. L., Pawelek J. M., Biology of hypopigmentation. Journal of the American Academy of Dermatology 1988 19 2 217 258 2-s2.0-0023716155
12. Hermanns J. F., Petit L., Martalo O., Piérard-Franchimont C., Cauwenbergh G., Piérard G. E., Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: effect of depigmenting agents. Dermatology 2000 201 2 118 122 2-s2.0-0033764692
13. Chuang T.-Y., Charles J., Reizner G. T., Elpern D. J., Farmer E. R., Melanoma in Kauai, Hawaii, 1981-1990: the significance of in situ melanoma and the incidence trend. International Journal of Dermatology 1999 38 2 101 107 2-s2.0-0033011941 10.1046/j.1365-4362.1999.00511.x (Pubitemid 29136860)
14. Hall H. I., Miller D. R., Rogers J. D., Bewerse B., Update on the incidence and mortality from melanoma in the United States. Journal of the American Academy of Dermatology 1999 40 1 35 42 2-s2.0-0033011011 10.1016/S0190-9622(99)70562-1 (Pubitemid 29051022)
15. van der Rhee H. J., van der Spek-Keijser L. M. T., van Westering R., Coebergh J. W. W., Increase in and stabilization of incidence and mortality of primary cutaneous malignant melanoma in western Netherlands, 1980-1195. British Journal of Dermatology 1999 140 3 463 467 2-s2.0-0032939380 10.1046/j.1365-2133. 1999.02710.x (Pubitemid 29182878)
16. Radović-Kovacević V., Pekmezović T., Adanja B., Jarebinski M., Marinković J., Tomin R., Survival analysis in patients with cutaneous malignant melanoma. Srpski Arhiv Za Celokupno Lekarstvo 1997 125 5-6 132 137 2-s2.0-0031134528
17. MacLennan R., Green A. C., McLeod G. R. C., Martin N. G., Increasing incidence of cutaneous melanoma in Queensland, Australia. Journal of the National Cancer Institute 1992 84 18 1427 1432 2-s2.0-0026648694
18. Dennis L. K., Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Archives of Dermatology 1999 135 3 275 280 2-s2.0-0032925323 (Pubitemid 29159209)
19. Swerlick R. A., Chen S., The melanoma epidemic: is increased surveillance the solution or the problem? Archives of Dermatology 1996 132 8 881 884 2-s2.0-0029737027 10.1001/archderm.132.8.881 (Pubitemid 26268589)
20. Swerlick R. A., The melanoma epidemic: more apparent than real? Mayo Clinic Proceedings 1997 72 6 559 564 2-s2.0-0030758591 (Pubitemid 27330267)
21. Czarnecki D., Meehan C. J., Is the incidence of malignant melanoma decreasing in young Australians? Journal of the American Academy of Dermatology 2000 42 4 672 674 2-s2.0-0033942003 (Pubitemid 30479894)
22. Kelly J. W., Melanoma in the elderly. A neglected public health challenge. Medical Journal of Australia 1998 169 8 403 404 2-s2.0-0032547746 (Pubitemid 28497682)
23. Shafir R., Hiss J., Tsur H., Bubis J. J., The thin malignant melanoma. Changing patterns of epidemiology and treatment. Cancer 1982 50 4 817 819 2-s2.0-0019950059 (Pubitemid 12052738)
24. MacKie R. M., Melanoma and the dermatologist in the third millennium. Archives of Dermatology 2000 136 1 71 73 2-s2.0-0033982601
25. Richert S. M., D'Amico F., Rhodes A. R., Cutaneous melanoma: patient surveillance and tumor progression. Journal of the American Academy of Dermatology 1998 39 4 571 577 2-s2.0-0031691813 10.1016/S0190-9622(98)70006-4 (Pubitemid 28465880)
26. Katsambas A., Nicolaidou E., Cutaneous malignant melanoma and sun exposure: recent developments in epidemiology. Archives of Dermatology 1996 132 4 444 450 2-s2.0-0029919947 10.1001/archderm.132.4.444 (Pubitemid 26113396)
27. Beral V., Evans S., Shaw H., Milton G., Cutaneous factors related to the risk of malignant melanoma. British Journal of Dermatology 1983 109 2 165 172 2-s2.0-0020579917 (Pubitemid 13078733)
28. Whiteman D. C., Green A. C., Melanoma and sun exposure: where are we now? International Journal of Dermatology 1999 38 7 481 489 2-s2.0-0032815303 10.1046/j.1365-4362.1999.00712.x (Pubitemid 29331924)
29. Schreiber M. M., Moon T. E., Bozzo P. D., Chronic solar ultraviolet damage associated with malignant melanoma of the skin. Journal of the American Academy of Dermatology 1984 10 5 755 759 2-s2.0-0021366171 (Pubitemid 14145585)
30. Green A., MacLennan R., Youl P., Martin N., Site distribution of cutaneous melanoma in Queensland. International Journal of Cancer 1993 53 2 232 236 2-s2.0-0027475624 10.1002/ijc.2910530210 (Pubitemid 23042871)
31. Beitner H., Ringborg U., Wennersten G., Lagerlof B., Further evidence for increased ligh sensitivity in patients with malignant melanoma. British Journal of Dermatology 1981 104 3 289 294 2-s2.0-0019394697 (Pubitemid 11060741)
32. Mikkilineni R., Weinstock M. A., Is the self-counting of moles a valid method of assessing melanoma risk? Archives of Dermatology 2000 136 12 1550 1551 2-s2.0-0034529910 (Pubitemid 32009279)
33. Schneider J. S., Moore D. H. II, Sagebiel R. W., Risk factors for melanoma incidence in prospective follow-up: the importance of atypical (dysplastic) nevi. Archives of Dermatology 1994 130 8 1002 1007 2-s2.0-0027990432 10.1001/archderm.130.8.1002 (Pubitemid 24255032)
34. Newton J. A., Bataille V., Griffiths K., Squire J. M., Sasieni P., Cuzick J., Bishop D. T., Swerdlow A., How common is the atypical mole syndrome phenotype in apparently sporadic melanoma? Journal of the American Academy of Dermatology 1993 29 6 989 996 2-s2.0-0027369387 (Pubitemid 23360333)
35. Naldi L., Imberti G. L., Parazzini F., Gallus S., La Vecchia C., Cainelli T., Rebora A., Tognoni G., Peserico A., Arcangeli F., Calista D., Landi G., Di Landro A., Puiatti P., Catricalà C., Eibenschutz L., Gallicano R. S., Lo Scocco G., Di Lernia V., Tosti A., Misciali C., Scardigli F., Cristofolini M., Simonacci M., Sigona M., Pasolini G., Manganoni A., Lonati A., Betti R., Barba A., De Agostini F., Chieregato C., Fabbrocini G., Balato N., Santoianni P., Bertazzoni M. G., Danese P., Stanganelli I., Moretti S., Carli Y. P., Iannantuono M., Taddeucci P., Virgili A., Fenizi G., Rossi E., Pini M., Galbiati G., Locatelli A., Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the italian population: results of a collaborative case-control study. Cancer 2000 88 12 2703 2710 2-s2.0-0034660237 10.1002/1097-0142(20000615)88: 12<2703::AID-CNCR8>3.0.CO;2-Q (Pubitemid 30417930)
36. Lee J. Y.-Y., Kapadia S. B., Musgrave R. H., Futrell W. J., Neurotropic malignant melanoma occurring in a stable burn scar. Journal of Cutaneous Pathology 1992 19 2 145 150 2-s2.0-0026551105
37. Rockley P. F., Trieff N., Wagner R. F. Jr., Tyring S. K., Nonsunlight risk factors for malignant melanoma part I: chemical agents, physical conditions, and occupation. International Journal of Dermatology 1994 33 6 398 406 2-s2.0-0028300983 (Pubitemid 24223155)
38. B. S. G., Colcleugh R. G., Scilley C. G., Craig I. D., Melanoma arising in a chronic (Marjolin's) ulcer. Journal of the American Academy of Dermatology 1995 32 6 1058 1059 2-s2.0-0029055162 10.1016/0190-9622(95)91364-5
39. Merkle T., Landthaler M., Eckert F., Braun-Falco O., Acral verrucous malignant melanoma in an immunosuppressed patient after kidney transplantation. Journal of the American Academy of Dermatology 1991 24 3 505 506 2-s2.0-0026061026
40. Grange F., Chompret A., Guilloud-Bataille M., Guillaume J.-C., Margulis A., Prade M., Demenais F., Avril M.-F., Comparison between familial and nonfamilial melanoma in France. Archives of Dermatology 1995 131 10 1154 1159 2-s2.0-0029130598
41. Greene M. H., Goldin L. R., Clark W. H. Jr., Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proceedings of the National Academy of Sciences of the United States of America 1983 80 19 6071 6075 2-s2.0-0021063979 (Pubitemid 14228246)
42. Dolianitis C., Kelly J., Wolfe R., Simpson P., Comparative performance of 4 dermoscopic algorithms by nonexperts for the diagnosis of melanocytic lesions. Archives of Dermatology 2005 141 8 1008 1014 2-s2.0-24044522569 10.1001/archderm.141.8.1008 (Pubitemid 46165524)
43. Clark W. H. Jr., Montagna W., Hu F., A classification of malignant melanoma in man correlated with histigenesis and biological behaviour. Advances in the Biology of the Skin, Vol III 1967 New York, NY, USA Pergamon 621 647
44. Clark W. H. Jr., From L., Bernardino E. A., Mihm M. C., The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Research 1969 29 3 705 727 2-s2.0-0014481136
45. Reed R. J., Acral lentiginous melanoma. New Concepts in Surgical Pathology of the Skin 1976 New York, NY, USA Wiley 89 90
46. Guerry D.-P. IV, Synnestvedt M., Elder D. E., Schultz D., Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. Journal of Investigative Dermatology 1993 100 3 342S 345S 2-s2.0-0027483342 (Pubitemid 23083195)
47. Taran J. M., Heenan P. J., Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis. Cancer 2001 91 9 1822 1825 2-s2.0-0035341095 10.1002/1097-0142(20010501)91:9<1822::AID- CNCR1202>3.0.CO;2-Y (Pubitemid 32377970)
48. Demitsu T., Nagato H., Nishimaki K., Okada O., Kubota T., Yoneda K., Manabe M., Melanoma in situ of the penis. Journal of the American Academy of Dermatology 2000 42 2 386 388 2-s2.0-0033926898 (Pubitemid 30463698)
49. Plotnick H., Rachmaninoff N., VandenBerg H. J. Jr., Polypoid melanoma: a virulent variant of nodular melanoma. Journal of the American Academy of Dermatology 1990 23 5 880 884 2-s2.0-0025083777 (Pubitemid 20366099)
50. Kiene P., Petres-Dunsche C., Folster-Holst R., Pigmented pedunculated malignant melanoma. A rare variant of nodular melanoma. British Journal of Dermatology 1995 133 2 300 302 2-s2.0-0029165231 10.1111/j.1365-2133.1995. tb02633.x
51. Cohen L. M., Lentigo maligna and lentigo maligna melanoma. Journal of the American Academy of Dermatology 1995 33 6 923 939 2-s2.0-0028801355
52. Weinstock M. A., Sober A. J., The risk of progression of lentigo maligna to lentigo maligna melanoma. British Journal of Dermatology 1987 116 3 303 310 2-s2.0-0023151005 (Pubitemid 17030533)
53. Hill D. C., Gramp A. A., Surgical treatment of lentigo maligna and lentigo maligna melanoma. Australasian Journal of Dermatology 1999 40 1 25 30 2-s2.0-0033049954 10.1046/j.1440-0960.1999.00311.x (Pubitemid 29128087)
54. Johnson T. M., Headington J. T., Baker S. R., Lowe L., Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the "square" procedure. Journal of the American Academy of Dermatology 1997 37 5 758 764 2-s2.0-0030671011 (Pubitemid 27500321)
55. Breuninger H., Schiagenhauff B., Stroebel W., Schaumburg-Lever G., Rassner G., Patterns of local horizontal spread of melanomas: consequences for surgery and histopathologic investigation. American Journal of Surgical Pathology 1999 23 12 1493 1498 2-s2.0-0032710344 10.1097/00000478-199912000- 00006
56. Chen Y.-J., Wu C.-Y., Chen J.-T., Shen J.-L., Chen C.-C., Wang H.-C., Clinicopathologic analysis of malignant melanoma in Taiwan. Journal of the American Academy of Dermatology 1999 41 6 945 949 2-s2.0-0032717131
57. Kuchelmeister C., Schaumburg-Lever G., Garbe C., Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. British Journal of Dermatology 2000 143 2 275 280 2-s2.0-0033847169 10.1046/j.1365-2133.2000.03651.x (Pubitemid 30650393)
58. Ronan S. G., Eng A. M., Briele H. A., Walker M. J., Das Gupta T. K., Malignant melanoma of the female genitalia. Journal of the American Academy of Dermatology 1990 22 3 428 435 2-s2.0-0025311616 (Pubitemid 20212395)
59. Batsakis J. G., Suarez P., Mucosal melanomas: a review. Advances in Anatomic Pathology 2000 7 3 167 180 2-s2.0-0034186508
60. Whitaker D. C., Argenyi Z., Smith A. C., Desmoplastic malignant melanoma: rare and difficult to diagnose. Journal of the American Academy of Dermatology 1992 26 5 704 709 2-s2.0-0026704109
61. Jain S., Allen P. W., Desmoplastic malignant melanoma and its variants. A study of 45 cases. American Journal of Surgical Pathology 1989 13 5 358 373 2-s2.0-0024524489 (Pubitemid 19134066)
62. Wong T.-Y., Suster S., Duncan L. M., Mihm M. C. Jr., Nevoid melanoma: a clinicopathological study of seven cases of malignant melanoma mimicking spindle and epithelioid cell nevus and verrucous dermal nevus. Human Pathology 1995 26 2 171 179 2-s2.0-0028887402
63. Schmoeckel C., Castro C. E., Braun-Falco O., Nevoid malignant melanoma. Archives of Dermatological Research 1985 277 5 362 369 2-s2.0-0021795854 (Pubitemid 15059777)
64. Reed R. J., Minimal deviation melanoma. Human Pathology 1990 21 12 1206 1211 2-s2.0-0025678355
65. Breslow A., Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Annals of Surgery 1970 172 5 902 908 2-s2.0-0014884119
66. Clemente C. G., Mihm M. C. Jr., Bufalino R., Zurrida S., Collini P., Cascinelli N., Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996 77 7 1303 1310 2-s2.0-0029925375 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID- CNCR12>3.0.CO;2-5 (Pubitemid 26102328)
67. Ronan S. G., Eng A. M., Briele H. A., Shioura N. N., Das Gupta T. K., Thin malignant melanomas with regression and metastases. Archives of Dermatology 1987 123 10 1326 1330 2-s2.0-0023270895 (Pubitemid 17152295)
68. Byers H. R., Bhawan J., Pathologic parameters in the diagnosis and prognosis of primary cutaneous melanoma. Hematology/Oncology Clinics of North America 1998 12 4 717 735 2-s2.0-0031710009 10.1016/S0889-8588(05)70020-4 (Pubitemid 28410372)
69. Mraz-Gernhard S., Sagebiel R. W., Kashani-Sabet M., Miller J. R. III, Leong S. P. L., Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. Archives of Dermatology 1998 134 8 983 987 2-s2.0-0031904085 (Pubitemid 28385320)
70. Bataille V., Genetics of familial and sporadic melanoma. Clinical and Experimental Dermatology 2000 25 6 464 470 2-s2.0-0033774813 10.1046/j.1365-2230.2000.00689.x
71. Nagore E., Climent J., Planelles M. D., Ledesma E., Rubio-Moscardo F., Fortea J. M., Oliver V., Analysis of the CDKN2A and CDK4 genes and HLA-DR and HLA-DQ alleles in two Spanish familial melanoma kindreds. Acta Dermato-Venereologica 2000 80 6 440 442 2-s2.0-0034489513 10.1080/ 000155500300012936 (Pubitemid 32156229)
72. Bataille V., Genetic epidemiology of melanoma. European Journal of Cancer 2003 39 10 1341 1347 2-s2.0-0038122762 10.1016/S0959-8049(03)00313-7 (Pubitemid 36773775)
73. Greulich K. M., Utikal J., Peter R.-U., Krähn G., c-MYC and nodular malignant melanoma: a case report. Cancer 2000 89 1 97 103 2-s2.0-0034235249 10.1002/1097-0142(20000701)89:1<97::AID-CNCR14>3.0.CO;2-0 (Pubitemid 30451279)
74. Bastian B. C., Olshen A. B., LeBoit P. E., Pinkel D., Classifying melanocytic tumors based on DNA copy number changes. American Journal of Pathology 2003 163 5 1765 1770 2-s2.0-0142151099 (Pubitemid 37310008)
75. Cowan J. M., Halaban R., Francke U., Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. Journal of the National Cancer Institute 1988 80 14 1159 164 2-s2.0-0023742620
76. Gerami P., Jewell S. S., Morrison L. E., Blondin B., Schulz J., Ruffalo T., Matushek P. IV, Legator M., Jacobson K., Dalton S. R., Charzan S., Kolaitis N. A., Guitart J., Lertsbarapa T., Boone S., LeBoit P. E., Bastian B. C., Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. American Journal of Surgical Pathology 2009 33 8 1146 1156 2-s2.0-67650283437 10.1097/PAS.0b013e3181a1ef36
77. Morey A. L., Murali R., McCarthy S. W., Mann G. J., Scolyer R. A., Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology 2009 41 4 383 387 2-s2.0-68849115096 10.1080/00313020902915875
78. Uong A., Zon L. I., zon@enders.tch.harvard.edu Melanocytes in development and cancer. Journal of Cellular Physiology 2010 222 1 38 41 2-s2.0-0034142326 10.1002/jcp.21935
79. Eager R. M., eager.rm@gmail.com Casey C. C., ccunningham@terapio.com Senzer N. N., NSenzer@marycrowley.org Stephenson Jr. J., Joe. Stephenson@USOncology.com Anthony S. P., stephen.anthony@usoncology.com O'Day S. J., soday@theangelesclinic.org Frenette G., gfrenette@carolinas.org Pavlick A. C., anna.pavlick@nyumc.org Jones B., bjones@ziopharm.com Uprichard M., muprichard@epixpharma.com Nemunaitis J., JNemunaitis@marycrowley.org Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma. BMC Cancer 2009 9, article 263 2-s2.0-0035881074 10.1186/1471-2407-9-263
80. Palmieri G., Capone M., Ascierto M. L., Gentilcore G., Stroncek D. F., Casula M., Sini M. C., Palla M., Mozzillo N., Ascierto P. A., Main roads to melanoma. Journal of Translational Medicine 2009 7, article 86 2-s2.0-71149083533 10.1186/1479-5876-7-86
81. Karim R. Z., Li W., Sanki A., Colman M. H., Yang Y. H., Thompson J. F., Scolyer R. A., Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors. International Journal of Surgical Pathology 2009 17 5 361 367 2-s2.0-70349554667 10.1177/1066896909336177
82. Villares G. J., Dobroff A. S., Wang H., Zigler M., Melnikova V. O., Huang L., Bar-Eli M., Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Research 2009 69 16 6730 6737 2-s2.0-69249096952 10.1158/0008-5472.CAN-09-0300
83. Blackburn J. S., Liu I., Coon C. I., Brinckerhoff C. E., A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis. Oncogene 2009 28 48 4237 4248 2-s2.0-71349087406 10.1038/onc.2009.272
84. Oka M., Kikkawa U., Protein kinase C in melanoma. Cancer and Metastasis Reviews 2005 24 2 287 300 2-s2.0-21544442035 10.1007/s10555-005-1578-8 (Pubitemid 40922800)
85. Hsu M.-Y., Shifts in cadherin profiles between human normal melanocytes and melanomas. Journal of Investigative Dermatology 1996 1 2 188 194 (Pubitemid 126759364)
86. Sviatoha V., vitalijs.svjatoha@karolinska.se Tani E., Kleina R., Sperga M., Skoog L., Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours. Melanoma Research 2010 20 2 118 125 2-s2.0-0020361371 10.1097/CMR.0b013e3283350554
87. Alla V., Engelmann D., Niemetz A., E2F1 in melanoma progression and metastasis. Journal of the National Cancer Institute 2010 102 2 127 133 2-s2.0-33750902614 10.1093/jnci/djp458
88. Mehnert J. M., mehnerja@umdnj.edu McCarthy M. M., Jilaveanu L., Flaherty K. T., Aziz S., Camp R. L., Rimm D. L., Kluger H. M., Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays. Human Pathology 2010 41 3 375 384 2-s2.0-66849095271 10.1016/j.humpath.2009.08.016
89. Xu X.-Z., Garcia M. V., Li T.-Y., Khor L.-Y., Gajapathy R. S., Spittle C., Weed S., Lessin S. R., Wu H., hong.wu@fccc.edu Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Modern Pathology 2010 23 2 187 196 2-s2.0-33646476831 10.1038/modpathol.2009.157
90. Degenhardt Y., yan.y.degenhardt@gsk.com Huang J., Greshock J., Horiates G., Nathanson K., Yang X., Herlyn M., Weber B., Distinct MHC gene expression patterns during progression of melanoma. Genes Chromosomes and Cancer 2010 49 2 144 154 2-s2.0-0037341162 10.1002/gcc.20728
91. Orgaz J. L., Ladhani O., Hoek K. S., Fernández-Barral A., Mihic D., Aguilera O., Seftor E. A., Bernad A., Rodríguez-Peralto J. L., Hendrix M. J. C., Volpert O. V., Jiménez B., Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma. Oncogene 2009 28 47 4147 4161 2-s2.0-70949107165 10.1038/onc.2009.284
92. Mueller D. W., Rehli M., Bosserhoff A. K., MiRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. Journal of Investigative Dermatology 2009 129 7 1740 1751 2-s2.0-67449119421 10.1038/jid.2008.452
93. Yang J., Price M. A., Gui Y. L., Bar-Eli M., Salgia R., Jagedeeswaran R., Carlson J. H., Ferrone S., Turley E. A., McCarthy J. B., Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition. Cancer Research 2009 69 19 7538 7547 2-s2.0-70350227318 10.1158/0008-5472.CAN-08-4626
94. Jilaveanu L. B., Zito C. R., Aziz S. A., Conrad P. J., Schmitz J. C., Sznol M., Camp R. L., Rimm D. L., Kluger H. M., C-Raf is associated with disease progression and cell proliferation in a subset of melanomas. Clinical Cancer Research 2009 15 18 5704 5713 2-s2.0-70349445575 10.1158/1078-0432.CCR-09-0198
95. Heimerl S., Bosserhoff A. K., Langmann T., Ecker J., Schmitz G., Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells. Melanoma Research 2007 17 5 265 273 2-s2.0-34648860593 10.1097/CMR.0b013e3282a7e0b9 (Pubitemid 47462218)
96. Meije C. B., Das P. K., Jans M. M. E., Hau C., van der Wal A. C., Alders M., Hakvoort T. B. M., Weidle U. H., Lamers W. H., Swart G. W. M., Multiple complementary transcripts of pCMaI, a novel gene located at chromosome 11p15.1-2, and melanocytic cell transformation. Journal of Pathology 2002 197 5 668 676 2-s2.0-0036056585 10.1002/path.1152
97. Kenessey I., Simon E., Futosi K., Antimigratory and antimetastatic effect of heparin-derived 4-18 unit oligosaccharides in a preclinical human melanoma metastasis model. Thrombosis and Haemostasis 2009 102 6 1265 1273 2-s2.0-26444601121 10.1160/TH09-01-0059
98. Rogers R. S. III, Malignant melanoma in the 21st century. International Journal of Dermatology 2000 39 3 178 179 2-s2.0-0033997554 10.1046/j.1365-4362. 2000.00875.x (Pubitemid 30223878)
99. Marks R., Epidemiology of melanoma. Clinical and Experimental Dermatology 2000 25 6 459 463 2-s2.0-0033770358 10.1046/j.1365-2230.2000.00693.x
100. Johnson T. M., Smith J. W. II, Nelson B. R., Chang A., Current therapy for cutaneous melanoma. Journal of the American Academy of Dermatology 1995 32 5 689 707 2-s2.0-0028947518 10.1016/0190-9622(95)91443-9
101. Green M. S., The changing controversy over surgical resection margins for stage I cutaneous melanoma. Mount Sinai Journal of Medicine 1991 58 4 341 346 2-s2.0-0026228137
102. O'Rourke M. G. E., Altmann C. R., Melanoma recurrence after excision: is a wide margin justified? Annals of Surgery 1993 217 1 2 5 2-s2.0-0027411123 (Pubitemid 23033211)
103. Balch C. M., Urist M. M., Karakousis C. P., Smith T. J., Temple W. J., Drzewiecki K., Jewell W. R., Bartolucci A. A., Mihm M. C. Jr., Barnhill R., Wanebo H. J., Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm): results of a multi-institutional randomized surgical trial. Annals of Surgery 1993 218 3 262 269 2-s2.0-0027169738 (Pubitemid 23270381)
104. Ringborg U., Andersson R., Eldh J., Glaumann B., Hafström L., Jacobsson S., Jönsson P.-E., Johansson H., Krysander L., Lagerlöf B., Christer L., Bjorn N., Carl-Magnus R., Erik R. L., Gunnar W., Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: a randomized study by the Swedish Melanoma Study Group. Cancer 1996 77 9 1809 1814 2-s2.0-15844393900 10.1002/(SICI)1097-0142(19960501)77:9<1809: :AID-CNCR8>3.0.CO;2-6 (Pubitemid 26125180)
105. Walsh P., Gibbs P., Gonzalez R., Rene.Gonzalez@UCHSC.edu Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease. Journal of the American Academy of Dermatology 2000 42 3 480 489 2-s2.0-0033910314 (Pubitemid 30470358)
106. Kandamany N., Mahaffey P., Carbon dioxide laser ablation as first-line management of in-transit cutaneous malignant melanoma metastases. Lasers in Medical Science 2009 24 3 411 414 2-s2.0-67349200997 10.1007/s10103-008-0580-0
107. Balch C. M., balchch@jhmi.edu Gershenwald J. E., Soong S.-J., Thompson J. F., Atkins M. B., Byrd D. R., Buzaid A. C., Cochran A. J., Coit D. G., Ding S., Eggermont A. M., Flaherty K. T., Gimotty P. A., Kirkwood J. M., McMasters K. M., Mihm Jr. M. C., Morton D. L., Ross M. I., Sober A. J., Sondak V. K., Final version of 2009 AJCC melanoma staging and classification. Journal of Clinical Oncology 2009 27 36 6199 6206 2-s2.0-39149089000 10.1200/JCO.2009.23.4799
108. Buzaid A. C., Ross M. I., Balch C. M., Soong S.-J., McCarthy W. H., Tinoco L., Mansfield P., Lee J. E., Bedikian A., Eton O., Plager C., Papadopoulos N., Legha S. S., Benjamin R. S., Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. Journal of Clinical Oncology 1997 15 3 1039 1051 2-s2.0-0031043697 (Pubitemid 27106288)
109. Kefford R. F., Adjuvant therapy of cutaneous melanoma: the interferon debate. Annals of Oncology 2003 14 3 358 365 2-s2.0-0037352253 10.1093/annonc/mdg120 (Pubitemid 36367410)
110. Wang T. S., Johnson T. M., Cascade P. N., Redman B. G., Sondak V. K., Schwartz J. L., Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma. Journal of the American Academy of Dermatology 2004 51 3 399 405 2-s2.0-4444364185 10.1016/j.jaad.2004.02.017 (Pubitemid 39178667)
111. Johnson T. M., Bradford C. R., Gruber S. B., Sondak V. K., Schwartz J. L., Staging workup, sentinel node biopsy, and follow-up tests for melanoma: update of current concepts. Archives of Dermatology 2004 140 1 107 113 2-s2.0-0346499540 10.1001/archderm.140.1.107 (Pubitemid 38090277)
112. Neuman H. B., Patel A., Ishill N., Hanlon C., Brady M. S., Halpern A. C., Houghton A., Coit D. G., A single-institution validation of the AJCC staging system for stage IV melanoma. Annals of Surgical Oncology 2008 15 7 2034 2041 2-s2.0-46149093935 10.1245/s10434-008-9915-0
113. Bedikian A. Y., Johnson M. M., Warneke C. L., Papadopoulos N. E., Kim K., Hwu W.-J., McIntyre S., Hwu P., Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma. Cancer Investigation 2008 26 6 624 633 2-s2.0-46349098677 10.1080/07357900802027073 (Pubitemid 351918588)